485 related articles for article (PubMed ID: 26288485)
21. Severe carbamazepine-induced cutaneous reaction in the treatment of post-herpetic neuralgia. Case report.
Garcia JB; Ferro LS; Carvalho AB; da Rocha RM; de Souza LM
Rev Bras Anestesiol; 2010; 60(4):429-37. PubMed ID: 20659616
[TBL] [Abstract][Full Text] [Related]
22. [From facial pain to toxic epidermal necrolysis: a rare complication of carbamazepine usage].
Ahmadi M; van Hoeven L; Bokhoven K
Ned Tijdschr Geneeskd; 2017; 161():D1895. PubMed ID: 29171374
[TBL] [Abstract][Full Text] [Related]
23. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
Moon J; Kim TJ; Lim JA; Sunwoo JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Jeon D; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsia; 2016 Nov; 57(11):1879-1886. PubMed ID: 27666425
[TBL] [Abstract][Full Text] [Related]
24. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
25. Carbamazepine ('Tegretol') and toxic epidermal necrolysis: report of three cases with histopathological observations.
Breathnach SM; McGibbon DH; Ive FA; Black MM
Clin Exp Dermatol; 1982 Nov; 7(6):585-91. PubMed ID: 7151316
[No Abstract] [Full Text] [Related]
26. Carbamazepine-Induced Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Overlap Treated Successfully with Oral Cyclosporin: Case report and literature review.
Al Rajaibi R; Al Rumhi T; Al Abri AM
Sultan Qaboos Univ Med J; 2021 Aug; 21(3):491-494. PubMed ID: 34522420
[TBL] [Abstract][Full Text] [Related]
27. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics.
Mockenhaupt M; Messenheimer J; Tennis P; Schlingmann J
Neurology; 2005 Apr; 64(7):1134-8. PubMed ID: 15824335
[TBL] [Abstract][Full Text] [Related]
28. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
[TBL] [Abstract][Full Text] [Related]
29. Economic evaluation of HLA-B*15:02 screening for carbamazepine-induced severe adverse drug reactions in Thailand.
Rattanavipapong W; Koopitakkajorn T; Praditsitthikorn N; Mahasirimongkol S; Teerawattananon Y
Epilepsia; 2013 Sep; 54(9):1628-38. PubMed ID: 23895569
[TBL] [Abstract][Full Text] [Related]
30. Toxic epidermal necrolysis in patient with malignant astrocytoma.
Kaczmarska-Turek D; Bartnik P; Kacperczyk J; Orlewski J; Olszewska M; Krasnodębska-Kiljańska M
Pol Merkur Lekarski; 2016 Jan; 40(235):25-7. PubMed ID: 26891432
[TBL] [Abstract][Full Text] [Related]
31. T-cell receptor and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: understanding a hypersensitivity reaction.
Ko TM; Chen YT
Expert Rev Clin Immunol; 2012 Jul; 8(5):467-77. PubMed ID: 22882221
[TBL] [Abstract][Full Text] [Related]
32. Toxic epidermal necrolysis as a dermatological manifestation of drug hypersensitivity syndrome.
Petkov T; Pehlivanov G; Grozdev I; Kavaklieva S; Tsankov N
Eur J Dermatol; 2007; 17(5):422-7. PubMed ID: 17673387
[TBL] [Abstract][Full Text] [Related]
33. Acute generalised exanthematous pustulosis and toxic epidermal necrolysis induced by carbamazepine.
Goh TK; Pang SM; Thirumoorthy T; Goh SG
Singapore Med J; 2008 Jun; 49(6):507-10. PubMed ID: 18581028
[TBL] [Abstract][Full Text] [Related]
34. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Harr T; French LE
Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
[TBL] [Abstract][Full Text] [Related]
35. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
Teraki Y; Shibuya M; Izaki S
Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
[TBL] [Abstract][Full Text] [Related]
36. Risk estimates for drugs suspected of being associated with Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control study.
Lin MS; Dai YS; Pwu RF; Chen YH; Chang NC
Intern Med J; 2005 Mar; 35(3):188-90. PubMed ID: 15737140
[TBL] [Abstract][Full Text] [Related]
37. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Kulkantrakorn K; Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Prabmechai N; Vannaprasaht S; Chumworathayi P; Chen P; Sritipsukho P
Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
[TBL] [Abstract][Full Text] [Related]
38. Early toxic epidermal necrolysis syndrome post-intra-cranial tumor resection.
Ramachandren TK; Petrilli RM
Scott Med J; 2016 Nov; 61(4):200-202. PubMed ID: 26659455
[TBL] [Abstract][Full Text] [Related]
39. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
Roujeau JC; Kelly JP; Naldi L; Rzany B; Stern RS; Anderson T; Auquier A; Bastuji-Garin S; Correia O; Locati F
N Engl J Med; 1995 Dec; 333(24):1600-7. PubMed ID: 7477195
[TBL] [Abstract][Full Text] [Related]
40. Early gynaecological assessment following Stevens-Johnson syndrome/toxic epidermal necrolysis.
Madhuri TK; Kremer C
J Obstet Gynaecol; 2010; 30(8):871-2. PubMed ID: 21126137
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
